Stock listing
NASDAQ:ORTX Orchard Therapeutics PLC Stock
Follow Orchard Therapeutics PLC into a list and get an email when it puts out news.
Last close · NASDAQ:ORTX
$16.70 USD
Close on Jan 25, 2024 · No longer trades
- Lowest – highest close
- $4.58 – $16.70 USDSince Mar 10, 2023 · lowest Mar 17, 2023 · highest Jan 23, 2024
Delisted NASDAQ:ORTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ORTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Orchard Therapeutics PLC on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Aug 3, 2023
- Decks
- 8 decks · latest Aug 3, 2023
Events
| Call | When | Status |
|---|---|---|
| Orchard Therapeutics (ORTX) Q2 2023 Earnings Call | Thu, Aug 03, 2023 · 8:00 AM ET | Replay |
| Orchard Therapeutics (ORTX) Q1 2022 Earnings Call | Thu, May 12, 2022 · 8:00 AM ET | Replay |
| Orchard Therapeutics (ORTX) Q4 2021 Earnings Call | Wed, Mar 30, 2022 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2023 Earnings Presentation | Earnings | 19 slides | Aug 3, 2023 |
| Technical Presentation (May 2023) | Technical | 41 slides | May 23, 2023 |
| Investor Presentation (January 2023) | Investor deck | 27 slides | Jan 9, 2023 |
| Technical Presentation (December 2022) | Technical | 40 slides | Dec 12, 2022 |
| 40th Annual J.P. Morgan Healthcare Conference (January 2022) | Conference | 25 slides | Jan 10, 2022 |
| 2021 JP Morgan Healthcare Conference | Conference | 23 slides | Jan 11, 2021 |
| Conference Presentation (January 2020) | Conference | 27 slides | Jan 13, 2020 |
| Conference Presentation (January 2019) | Conference | 25 slides | Jan 7, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Feb 9, 2021 – Feb 9, 2021 · Past |
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past) | Director · Jan 1, 2020 – Jan 24, 2024 · Past |
| James Geraghty Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Juniper Pharmaceuticals Inc (Director · Aug 2, 2016 – Aug 14, 2018 · Past); Aceragen Inc. (Director · May 13, 2016 – Jun 23, 2022 · Past) | Director · Jan 1, 2020 – Jan 24, 2024 · Past |
| Frank E Thomas Other companies: Spero Therapeutics, Inc. (Director · Since at least Nov 1, 2017); Larimar Therapeutics, Inc. (Director · Since at least Jun 30, 2016); AMAG Pharmaceuticals Inc (President & COO · Feb 23, 2017 – Feb 23, 2017 · Past) | See Remarks · Jan 1, 2020 – Jan 24, 2024 · Past |
| Joanne T Beck Other companies: Astria Therapeutics Inc (Director · Since at least Feb 13, 2019) | Director · Jan 1, 2020 – Jan 24, 2024 · Past |
| Jon Ellis | Director · Jan 1, 2020 – Jan 1, 2020 · Past |
| Marc Dunoyer | Director · Jun 16, 2021 – Jan 24, 2024 · Past |
Log in to ask 6ix AI your own questions about Orchard Therapeutics PLC.